Human equivalent dose (HED) is a widely used concept in drug development, but it has limitations in accurately predicting the appropriate dose for humans based on animal studies alone. In this article, we will explore the limitations of HED and some of the alternatives that researchers are using to better predict drug dosing in humans.
Limitations of HED
One of the main limitations of HED is the assumption that metabolic rate scales predictably with body weight across species. However, metabolic rate can vary between species and can be affected by factors such as age, gender, and disease state. This variability can make it difficult to accurately predict the appropriate dosage for humans based on animal studies alone.
Another limitation of HED is the lack of consideration for other factors that can affect drug metabolism and response in humans, such as genetic differences and drug-drug interactions. HED calculations assume that all humans have the same metabolic rate and response to a drug, which is not always the case (Human Equivalent Calculator).
Alternatives to HED
To address some of the limitations of HED, researchers are exploring alternative methods for predicting drug dosing in humans. Here are a few examples:
Allometric scaling based on clearance: Clearance is a measure of how quickly the body eliminates a drug from the bloodstream. Allometric scaling based on clearance involves adjusting the dose based on the estimated clearance rate in humans, rather than just body weight. This method takes into account the differences in metabolic rate and drug elimination between species and can be a more accurate predictor of dosing in humans.
Physiologically-based pharmacokinetic (PBPK) modeling: PBPK modeling involves creating a computer model of the human body to simulate how a drug is absorbed, distributed, metabolized, and eliminated. This method takes into account factors such as age, gender, and disease state that can affect drug metabolism and response in humans. PBPK modeling can be used to predict the appropriate dosage for humans based on animal studies, as well as to simulate the effects of different dosages and drug combinations.
Microdosing: Microdosing involves administering a subtherapeutic dose of a drug to humans to measure its pharmacokinetics and pharmacodynamics. This method allows researchers to directly measure how a drug is metabolized and eliminated in humans and can provide more accurate information on drug dosing than animal studies alone.
Human equivalent dose is a useful concept in drug development, but it has limitations in accurately predicting the appropriate dosage for humans based on animal studies alone. Researchers are exploring alternative methods for predicting drug dosing in humans, such as allometric scaling based on clearance, PBPK modeling, and microdosing. These methods take into account factors such as metabolic rate, genetic differences, and drug-drug interactions that can affect drug metabolism and response in humans. By using these alternative methods, researchers can more accurately predict the appropriate dosage for humans and improve the safety and efficacy of drugs in clinical trials.
Read More Science News